CA 19-9 抗体
(6 references)-
- 抗原 See all CA 19-9 抗体
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CA 19-9 antibody is un-conjugated
-
应用范围
- ELISA, Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Western Blotting (WB)
- 纯化方法
- IgM specific affinity chromatography
- 免疫原
- Ten precipitin lines obtained after immunodiffusion using monoclonal antibody NS 19-9 and mucins isolated from an ovarian cyst of a OLe (a+b-) patient
- 克隆位点
- 121SLE
- 亚型
- IgM
- Top Product
- Discover our top product CA 19-9 Primary Antibody
-
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibody
CA 19-9 适用: 人 ELISA, IHC (p) 宿主: 小鼠 Monoclonal 121SLE unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 适用: 人 IHC, StM 宿主: 兔 Monoclonal CA19-9-1390R unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 适用: 人 IHC, StM 宿主: 小鼠 Monoclonal 121SLE unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 适用: 人 IHC, FACS, IF, ISt 宿主: 小鼠 Monoclonal SPM588 unconjugated
anti-Gastrointestinal Cancer Antigen CA19-9 (CA 19-9) antibodyCA 19-9 适用: 人 FACS, IF, IHC (p) 宿主: 兔 Monoclonal CA19-9-1390R unconjugated Recombinant Antibody
-
- 应用备注
- Optimal antibody dilution should be determined by titration, however as a guideline try at 2 μg/mL on FFPE tissue
- 说明
-
Myeloma, fusion partners: Spleen cells from immunised BALB/c mice were fused with cells of the Sp2/0 myeloma line
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- Purified antibody in phosphate buffered saline containing 10 mM sodium azide
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
: "Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation." in: Proteomics, Vol. 12, Issue 13, pp. 2212-20, (2012) (PubMed).
: "Lectin histochemistry of metastasizing and non-metastasizing breast and colon cancer cells." in: Anticancer research, Vol. 31, Issue 5, pp. 1589-97, (2011) (PubMed).
: "CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity." in: World journal of gastroenterology : WJG, Vol. 17, Issue 24, pp. 2965-71, (2011) (PubMed).
: "E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung." in: British journal of cancer, Vol. 102, Issue 3, pp. 602-9, (2010) (PubMed).
: "Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997." in: Tumour biology, Vol. 19, Issue 5, pp. 390-420, (1998) (PubMed).
: "Ectopic expression of the Y (Ley) antigen defined by monoclonal antibody 12-4LE in distal colonic adenocarcinomas." in: International journal of cancer. Journal international du cancer, Vol. 41, Issue 5, pp. 683-9, (1988) (PubMed).
-
: "Diverse monoclonal antibodies against the CA 19-9 antigen show variation in binding specificity with consequences for clinical interpretation." in: Proteomics, Vol. 12, Issue 13, pp. 2212-20, (2012) (PubMed).
-
- 抗原
- CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
- 别名
- CA19-9 (CA 19-9 产品)
- 背景
-
Synonyms:
Sialyl Lewis (a) antibody,Sialyl Lewis(a) antibody,Sialyl Lewisa antibody
-
